EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Large Unilamellar Vesicles of Phosphatidic Acid Reduce the Toxicity of α-Synuclein Fibrils

Abid Ali, Aidan P Holman, Axell Rodriguez, Kiryl Zhaliazka, Luke Osborne, Dmitry Kurouski iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c01012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Abid Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a severe pathology that is caused by a progressive degeneration of dopaminergic neurons in substantia nigra pars compacta as well as other areas in the brain. These neurodegeneration processes are linked to the abrupt aggregation of α-synuclein (α-syn), a small protein that is abundant at presynaptic nerve termini, where it regulates cell vesicle trafficking. Due to the direct interactions of α-syn with cell membranes, a substantial amount of work was done over the past decade to understand the role of lipids in α-syn aggregation. However, the role of phosphatidic acid (PA), a negatively charged phospholipid with a small polar head, remains unclear. In this study, we examined the effect of PA large unilamellar vesicles (LUVs) on α-syn aggregation. We found that PA LUVs with 16:0, 18:0, and 18:1 FAs drastically reduced the toxicity of α-syn fibrils if were present in a 1:1 molar ratio with the protein. Our results also showed that the presence of these vehicles changed the rate of α-syn aggregation and altered the morphology and secondary structure of α-syn fibrils. These results indicate that PA LUVs can be used as a potential therapeutic strategy to reduce the toxicity of α-syn fibrils formed upon PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseHumansUnilamellar LiposomesDopaminergic Neurons

Stichwörter der Autor:innen

AFM-IRLDHfibrilsphosphatidic acidα-synuclein

Substanzen

alpha-SynucleinUnilamellar Liposomes

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States.
  • Department of Entomology, Texas A&M University, College Station, Texas 77843, United States.
  • Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, United States.

ORCID-Profile: Dmitry Kurouski

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Ali, A., Holman, A. P., Rodriguez, A., Zhaliazka, K., Osborne, L., & Kurouski, D. (2024). Large Unilamellar Vesicles of Phosphatidic Acid Reduce the Toxicity of α-Synuclein Fibrils. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01012

Vancouver

Ali A, Holman AP, Rodriguez A, Zhaliazka K, Osborne L, Kurouski D. Large Unilamellar Vesicles of Phosphatidic Acid Reduce the Toxicity of α-Synuclein Fibrils. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01012

BibTeX
@article{Ali2024,
  author = {Ali, Abid and Holman, Aidan P and Rodriguez, Axell and Zhaliazka, Kiryl and Osborne, Luke and Kurouski, Dmitry},
  title = {Large Unilamellar Vesicles of Phosphatidic Acid Reduce the Toxicity of α-Synuclein Fibrils},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c01012}
}
Kostenlos starten →